Editas Medicine (EDIT) Capital Leases (2016 - 2018)

Editas Medicine (EDIT) has 3 years of Capital Leases data on file, last reported at $32.4 million in Q4 2018.

• On a quarterly basis, Capital Leases fell 3.03% year-over-year to $32.4 million in Q4 2018; TTM through Dec 2018 was $32.4 million, a 3.03% decrease from a year earlier, with the FY2018 full-year figure at $32.4 million, down 3.03% from the prior year.
• Capital Leases for Q4 2018 stood at $32.4 million, down from $32.7 million in the prior quarter.
• Over the last five years, Capital Leases for EDIT reached as high as $35.1 million in Q4 2016 and fell as low as $11.6 million in Q1 2016.
• Historically, Capital Leases has averaged $30.6 million across 3 years, with a median of $33.1 million in 2018.
• On a YoY basis, Capital Leases climbed as much as 191.26% in 2017 and fell as far as 4.74% in 2017.
• Year by year, Capital Leases stood at $35.1 million in 2016, then retreated by 4.74% to $33.4 million in 2017, then fell by 3.03% to $32.4 million in 2018.
• Per Business Quant data, the three most recent Capital Leases figures were $32.4 million in Q4 2018, $32.7 million in Q3 2018, and $32.9 million in Q2 2018.